QA: Alpine Immune Sciences INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2016_Alpine_Immune_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Immune Design CORP', 'shared_tokens': {'immune'}}]}

Graph

Absolute values for 0001626199, Alpine Immune Sciences INC

  xvar xval
0 AssetsCurrent 87,686,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 223,000
4 LiabilitiesCurrent 4,419,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,844,000
9 ResearchAndDevelopmentExpense 16,054,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 80,000
13 remainder_ComprehensiveNetIncome 3,000
  yvar yval
0 Assets 87,909,000
1 Liabilities 4,419,000
2 Expenses 22,898,000
3 Revenues 0
4 StockholdersEquity 83,490,000
5 NetIncome -22,818,000
6 ComprehensiveNetIncome -22,816,500
7 BaseVar 57,654,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.45
9 EconomicCapitalRatio 3.99

Edgar->Model Mapping

Feature Distribution